Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -78.14x is 35% below its 1-year average of -57.89x, near the low end of its 1-year range (-78.14x–-55.37x).
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-78.14x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 329 covered companies
CURRENT VS SECTOR MEDIAN
-1760.48%
vs the sector median at left
Alamar Biosciences, Inc.
Market Cap
$2.69B
Interest Coverage Ratio
-78.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.76B
Interest Coverage Ratio
-8.77x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.68B
Interest Coverage Ratio
2.79x
TTM Avg
3.64x
3Y Avg
5.04x
5Y Avg
5.11x
Market Cap
$2.68B
Interest Coverage Ratio
1.89x
TTM Avg
1.89x
3Y Avg
0.94x
5Y Avg
0.94x
Market Cap
$2.51B
Interest Coverage Ratio
-358.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.43B
Interest Coverage Ratio
-65.43x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.43B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.85B
Interest Coverage Ratio
-0.59x
TTM Avg
11.23x
3Y Avg
11.23x
5Y Avg
11.23x
Market Cap
$2.87B
Interest Coverage Ratio
7.88x
TTM Avg
5.24x
3Y Avg
5.24x
5Y Avg
5.24x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alamar Biosciences, Inc. (ALMR) | $2.69B | -78.14x | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.76B | -8.77x | N/A | N/A | N/A |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | 2.79x | 3.64x | 5.04x | 5.11x |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.68B | 1.89x | 1.89x | 0.94x | 0.94x |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | -358.08x | N/A | N/A | N/A |
| Disc Medicine, Inc. (IRON)vs › | $2.43B | -65.43x | N/A | N/A | N/A |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | N/A | N/A | N/A | N/A |
| AtriCure, Inc. (ATRC)vs › | $2.85B | -0.59x | 11.23x | 11.23x | 11.23x |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 7.88x | 5.24x | 5.24x | 5.24x |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.89B | -75.61x | 0.12x | 0.12x | 0.12x |
Interest Coverage
-78.1x
Debt/Equity
0.16
Current Ratio
11.85
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -60.41x |
| 2026-03-31 | -55.37x |
